Lead Author: von Ranke, et al.
Original date of publication: 07/25/2025
Link:
Summary Context
Using high-resolution RNA sequencing of blood samples and differential gene expression analysis the study discovered that COVID-19 mRNA injections can trigger profound, long-lasting genetic dysregulation in individuals who develop new-onset adverse events or cancer following vaccination. The study suggests that COVID-19 vaccines severely disrupt the expression of thousands of genes—inducing mitochondrial failure, immune system reprogramming, and oncogenic activation that persisted for months to years after injection.
Comments
The study enrolled adult participants (ages 18–70) who developed either new-onset symptoms following administration of mRNA-based COVID-19 vaccines (BNT162b2 [Pfizer] or mRNA-1273 [Moderna]). Among the symptomatic individuals with nonmalignant adverse events, reported manifestations included cardiovascular injury, thrombosis, chronic fatigue, and neurological dysfunction, emerging shortly after vaccination. Another group of participants was diagnosed with cancer as a new-onset condition within a short time frame following mRNA vaccine administration. The study population was divided into two groups: the first consisted of three individuals who developed new-onset post-vaccination symptoms, and the second included seven individuals with new-onset cancer diagnoses. A cohort of 803 healthy individuals was used as the reference control group.Methodological and interpretive critiques of the study highlight the small sample size and the fact that the controls were not randomly selected.The authors counter that these are not generalizable population statistics, but focused molecular snapshots of outlier pathology with the goal being mechanistic insight, not epidemiology. Noting that the post-vaccine cancer patients were low-risk individuals with no known cancer predisposition this reinforces that transcriptomic shifts are not explained by age or disease burden. The authors also contend that the study does not claim causality, but rather presents distinct transcriptomic signatures consistent with early oncogenesis or tumor-promoting shifts.The findings of the study are not intended to imply a statistical causation at this juncture but should encourage further precision surveillance. This is a mechanistic, hypothesis-generating research study—not a clinical trial.
Abstract or Results, Key Passages
“Background/Objectives: Synthetic mRNA vaccines have raised concerns regarding prolonged spike protein expression, immune activation, and potential off-target effects. This study investigates transcriptomic alterations in individuals with new-onset adverse events or cancer following mRNA COVID-19 vaccination. Methods: Bulk RNA sequencing was performed on peripheral blood from two patient groups: individuals with new-onset nonmalignant adverse events and individuals newly diagnosed with cancer post-vaccination. A control group of healthy individuals was used for comparison. Differential gene expression was analyzed using DESeq2, and Gene Set Enrichment Analysis (GSEA) was conducted using the MSigDB database and custom gene sets. Results: Both vaccine patient groups displayed widespread transcriptional dysregulation. In the nonmalignant adverse event group, hallmark enrichments included mitochondrial dysfunction, proteasome-mediated stress, transcriptomic instability, and systemic inflammation. The cancer group exhibited additional hallmarks of genomic instability, and epigenetic reprogramming. Nonsense-mediated decay (NMD), ribosomal stress, and MYC activation were prominent in both groups, while immune signaling via TLRs and type I interferons was particularly elevated in cancer patients. Conclusions: The observed transcriptomic profiles indicate persistent cellular stress responses, mitochondrial dysfunction, and immune dysregulation following exposure to mRNA vaccines, potentially in susceptible individuals. Shared and distinct molecular signatures in both cohorts demonstrate underlying mechanisms contributing to post-vaccine symptomatology and complications, including oncogenesis and or progression of malignant disease. These findings underscore the need for a deeper investigation into the long-term safety of mRNA vaccines and host response variability.”
Keywords: adverse eventscancerinflammationmitochondrial dysfunctionSpike proteintranscription
Full Author List: Natalia von Ranke, Wei Zhang,Philipp Anokin, Nicolas Hulscher, Kevin J. McKernan, Peter A. McCullough, John A. Catanzaro
